Price controls on pharmaceuticals will not lower prices and will lead to fewer future cures.
Regulating PBMs Will Not Lower Drug Costs
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
President Biden Again Tries to Undermine U.S. Biomedical Innovation
President Biden’s support of intellectual property waivers threatens development of future life-saving medicines.
Transparency is Needed Before More COVID-19 Aid is Approved
Congress and the rest of the federal government must increase transparency for taxpayers
Price Controls in the BBBA Will Destroy the Development of Future Cures
The price controls found in the BBBA leave patients worse off.
The New Year Is a New Chance to Restore Fiscal Sanity
Congress should resolve to pass policies that are fiscally responsible and alleviate the effects of inflation.
The Resurgence of the Build Back Better Act is Inevitable
The BBBA is more big government socialism, with a price tag of $4.9 trillion over 10 years.
Price Controls Will Create an Invisible Graveyard of Americans
The Build Back Better Act will cost lives by devastating the development of future cures.
Build Back Better Act: Not Dead Yet
The $1.75 trillion Build Back Better Act has had a tough week and is on life support.
President Biden Again Calls for Price Controls
President Biden’s Monday speech included the same dangerous and wrong solutions to lower drug costs.